Skip to main content
iSpecimen Inc. (ISPC)
NASDAQ: ISPC · Real-Time Price · USD
0.249
+0.002 (0.69%)
At close: Mar 6, 2026, 4:00 PM EST
0.256
+0.007 (2.73%)
After-hours: Mar 6, 2026, 7:59 PM EST

iSpecimen Revenue

iSpecimen had revenue of $106.59K in the quarter ending September 30, 2025, a decrease of -96.00%. This brings the company's revenue in the last twelve months to $3.35M, down -67.73% year-over-year. In the year 2024, iSpecimen had annual revenue of $9.29M, down -6.42%.

Revenue (ttm)
$3.35M
Revenue Growth
-67.73%
P/S Ratio
0.72
Revenue / Employee
$139,698
Employees
24
Market Cap
2.43M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20249.29M-637.07K-6.42%
Dec 31, 20239.93M-474.12K-4.56%
Dec 31, 202210.40M-733.00K-6.58%
Dec 31, 202111.14M2.95M36.06%
Dec 31, 20208.18M3.89M90.40%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Inotiv 514.03M
FONAR 106.03M
Biodesix 88.50M
Exagen 63.60M
XWELL 29.52M
Precipio 22.80M
bioAffinity Technologies 6.78M
Mainz Biomed 659.94K
Revenue Rankings

ISPC News

More News